On Friday, the German chemical and pharmaceutical group Bayer announced that it is going to enter in to Indian market with Zydus Cadila. The aim of such pact is to improve its presence in that country's fast growing market.

The new firm, Bayer Zydus Pharma will focus on women's healthcare, problem-solving imaging, general medicines and oncology as stated by Bayer in a statement.

Moreover, they will look forward to accelerate their capabilities for better service in the fast growing Indian market. This has been started by Joerg Reinhardt, chief executive of Bayer's HealthCare unit.

It is expected that the new company will comprise 600 staff. These staff members will be employed from the parent groups. On the other hand, the financial details are yet to be disclosed.

Today, Pharmaceutical firm Zydus Cadila has also said that it will form a joint venture with Germany's Bayer Healthcare with an aim to sell drugs in India.

According to the company, the partnership share of this new company will be equal. In addition, Bayer Zydus Pharma will operate in important parts along with the abovementioned aims.